Case number 1:20-cv-01064
Currax Pharmaceuticals LLC v. MSN Laboratories Private Limited et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 16, 2022 | 76 | STIPULATION and [Proposed] Order of Dismissal, by Currax Pharmaceuticals LLC. (O'Brien, Daniel) Modified on 11/16/2022 (nms). (Entered: 11/16/2022) (4) |
| Nov 16, 2022 | 77 | SO ORDERED Granting 76 Stipulation and Proposed Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 11/16/2022. (nms) (Entered: 11/16/2022) (4) |
| Nov 16, 2022 | 78 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,915,307; 9,532,971; 9,572,814; 9,907,780; 10,548,871; 10,653,660. (Attachments: # 1 Order)(nms) (Entered: 11/16/2022) (Main Document) (2) |
| Nov 16, 2022 | 78 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,915,307; 9,532,971; 9,572,814; 9,907,780; 10,548,871; 10,653,660. (Attachments: # 1 Order)(nms) (Entered: 11/16/2022) (Order) (4) |
| Nov 4, 2022 | 75 | SO ORDERED Granting 74 Joint Stipulation and [Proposed] Order to Stay Action Pending Settlement. Signed by Judge Richard G. Andrews on 11/4/2022. (nms) (Entered: 11/04/2022) (2) |
| Nov 3, 2022 | 74 | Joint Stipulation and [Proposed] Order to Stay Action Pending Settlement, by Currax Pharmaceuticals LLC. (O'Brien, Daniel) Modified on 11/4/2022 (nms). (Entered: 11/03/2022) (2) |
| Sep 21, 2022 | 72 | Joint Stipulation and [Proposed] Order to Stay Action Pending Settlement, by Currax Pharmaceuticals LLC. (O'Brien, Daniel) Modified on 9/21/2022 (nms). (Entered: 09/21/2022) (3) |
| Sep 21, 2022 | 73 | SO ORDERED Granting 72 Joint Stipulation and Proposed Order to Stay Action Pending Settlement. Signed by Judge Richard G. Andrews on 9/21/2022. (nms) (Entered: 09/21/2022) (2) |
| Jul 13, 2022 | 71 | Official Transcript of Markman Hearing held on 5/25/22 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/3/2022. Redacted Transcript Deadline set for 8/15/2022. Release of Transcript Restriction set for 10/11/2022. (Triozzi, Heather) (Entered: 07/13/2022) (43) |
| May 26, 2022 | 69 | Main Document (1) Docket Text: PROPOSED Order on Claim Construction, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Letter)(Ormerod, Eve) Modified on 5/26/2022 (nms). |
| May 26, 2022 | 69 | Letter (1) |
| May 26, 2022 | 70 | Order (1) Docket Text: ORDER ON CLAIM CONSTRUCTION. Signed by Judge Richard G. Andrews on 5/26/2022. (nms) |
| May 25, 2022 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 5/25/2022. Counsel for Plaintiff: D. O'Brien. Counsel for Defendants: E. Ormerod. Defendants are directed to submit a proposed order reflecting the rulings made at the hearing. (Court Reporter Heather Triozzi.) (lak) |
| May 24, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman Hearing scheduled for 5/25/2022, will now commence at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 5/24/2022. (nms) |
| Apr 25, 2022 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [64] MOTION for Claim Construction (nms) |
| Apr 25, 2022 | 67 | Order (2) Docket Text: SO ORDERED Granting [64] Joint Motion for Claim Construction. Signed by Judge Richard G. Andrews on 4/25/2022. (nms) |
| Apr 22, 2022 | 64 | Motion for Miscellaneous Relief (3) Docket Text: MOTION for Claim Construction - filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) Modified on 4/25/2022 (nms). Modified on 4/25/2022 (nms). |
| Apr 22, 2022 | 65 | Joint Claim Construction Brief (30) Docket Text: JOINT Claim Construction Brief, by Currax Pharmaceuticals LLC. (O'Brien, Daniel) Modified on 4/25/2022 (nms). |
| Apr 22, 2022 | 66 | Main Document (4) Docket Text: APPENDIX re [65] Joint Claim Construction Brief, by Currax Pharmaceuticals LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z, # (27) Exhibit AA, # (28) Exhibit BB, # (29) Exhibit CC, # (30) Exhibit DD, # (31) Exhibit EE, # (32) Exhibit FF, # (33) Exhibit GG, # (34) Exhibit HH, # (35) Exhibit II, # (36) Exhibit JJ, # (37) Exhibit KK, # (38) Exhibit LL, # (39) Exhibit MM)(O'Brien, Daniel) Modified on 4/25/2022 (nms). |
| Apr 22, 2022 | 66 | Exhibit A (48) |
| Apr 22, 2022 | 66 | Exhibit B (48) |
| Apr 22, 2022 | 66 | Exhibit C (42) |
| Apr 22, 2022 | 66 | Exhibit D (23) |
| Apr 22, 2022 | 66 | Exhibit E (22) |
| Apr 22, 2022 | 66 | Exhibit F (19) |
| Apr 22, 2022 | 66 | Exhibit G (18) |
| Apr 22, 2022 | 66 | Exhibit H (19) |
| Apr 22, 2022 | 66 | Exhibit I (20) |
| Apr 22, 2022 | 66 | Exhibit J (29) |
| Apr 22, 2022 | 66 | Exhibit K (18) |
| Apr 22, 2022 | 66 | Exhibit L (30) |
| Apr 22, 2022 | 66 | Exhibit M (25) |
| Apr 22, 2022 | 66 | Exhibit N (32) |
| Apr 22, 2022 | 66 | Exhibit O (12) |
| Apr 22, 2022 | 66 | Exhibit P (16) |
| Apr 22, 2022 | 66 | Exhibit Q (17) |
| Apr 22, 2022 | 66 | Exhibit R (14) |
| Apr 22, 2022 | 66 | Exhibit S (18) |
| Apr 22, 2022 | 66 | Exhibit T (12) |
| Apr 22, 2022 | 66 | Exhibit U (8) |
| Apr 22, 2022 | 66 | Exhibit V (7) |
| Apr 22, 2022 | 66 | Exhibit W (38) |
| Apr 22, 2022 | 66 | Exhibit X (42) |
| Apr 22, 2022 | 66 | Exhibit Y (32) |
| Apr 22, 2022 | 66 | Exhibit Z (50) |
| Apr 22, 2022 | 66 | Exhibit AA (17) |
| Apr 22, 2022 | 66 | Exhibit BB (19) |
| Apr 22, 2022 | 66 | Exhibit CC (16) |
| Apr 22, 2022 | 66 | Exhibit DD (18) |
| Apr 22, 2022 | 66 | Exhibit EE (28) |
| Apr 22, 2022 | 66 | Exhibit FF (19) |
| Apr 22, 2022 | 66 | Exhibit GG (15) |
| Apr 22, 2022 | 66 | Exhibit HH (16) |
| Apr 22, 2022 | 66 | Exhibit II (20) |
| Apr 22, 2022 | 66 | Exhibit JJ (20) |
| Apr 22, 2022 | 66 | Exhibit KK (23) |
| Apr 22, 2022 | 66 | Exhibit LL (5) |
| Apr 22, 2022 | 66 | Exhibit MM (21) |
| Apr 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [63] STIPULATION to Extend Time for the substantial completion of document production to June 28, 2022. Signed by Judge Richard G. Andrews on 4/18/2022. (nms) |
| Apr 14, 2022 | 63 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION to Extend Time for the substantial completion of document production to June 28, 2022 - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) Modified on 4/14/2022 (nms). |
| Apr 11, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher P. Borello, Zachary L Garrett, and Dominick A. Conde for Currax Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 8, 2022 | 62 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel) |
| Apr 4, 2022 | 61 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' 1) Response to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-73), and 2) Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-8) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Mar 30, 2022 | 60 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Currax's Objections and Reponses to MSN's First Set of Requests for the Production of Documents and Things (Nos. 1-101) and (ii) Currax's Objections and Responses to MSN's First Set of Interrogatories (Nos. 1-8) filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Mar 14, 2022 | 59 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Reply Claim Construction Brief filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Mar 7, 2022 | 58 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Plaintiff's First Set of Interrogatories (Nos. 1-8) and (ii) Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-73) filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Feb 25, 2022 | 57 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Interrogatories (Nos. 1-8) to Plaintiff Currax Pharmaceuticals LLC, and 2) Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-101) to Plaintiff Currax Pharmaceuticals LLC filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Feb 22, 2022 | 56 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Feb 18, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Howard Wang for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Feb 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [55] MOTION for Pro Hac Vice Appearance of Attorney Howard Wang, filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 2/17/2022. (nms) |
| Feb 17, 2022 | 55 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Howard Wang - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) |
| Jan 18, 2022 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Opening Claim Construction Brief filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Jan 6, 2022 | 53 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Appearance of Amit Singhai by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Ormerod, Eve) |
| Dec 15, 2021 | 52 | Order Setting Mediation Conferences (2) Docket Text: ORDER Setting Mediation Conferences: An ex parte Telephone Conference with counsel for Currax is set for 1/13/2022 at 11:00 AM before Judge Mary Pat Thynge. An ex parte Telephone Conference with counsel for MSN is set for 1/13/2022 at 11:20 AM before Judge Mary Pat Thynge. A joint Telephone Conference is set for 1/13/2022 at 11:40 AM before Judge Mary Pat Thynge. Counsel for Currax shall initiate the 11:40 AM joint call to chambers. See ORDER for additional details. Signed by Judge Mary Pat Thynge on 12/15/2021. (Taylor, Daniel) |
| Nov 23, 2021 | 51 | Main Document (4) Docket Text: Amended Claim Construction Chart, by Currax Pharmaceuticals LLC. (Attachments: # (1) Appendix A, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(O'Brien, Daniel) Modified on 11/23/2021 (nms). |
| Nov 23, 2021 | 51 | Appendix A (13) |
| Nov 23, 2021 | 51 | Exhibit A (15) |
| Nov 23, 2021 | 51 | Exhibit B (48) |
| Nov 23, 2021 | 51 | Exhibit C (17) |
| Nov 23, 2021 | 51 | Exhibit D (49) |
| Nov 23, 2021 | 51 | Exhibit E (42) |
| Nov 23, 2021 | 51 | Exhibit F (18) |
| Nov 23, 2021 | 51 | Exhibit G (140) |
| Nov 23, 2021 | 51 | Exhibit H (32) |
| Nov 23, 2021 | 51 | Exhibit I (160) |
| Nov 23, 2021 | 51 | Exhibit J (79) |
| Nov 3, 2021 | 50 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Currax Pharmaceuticals LLC's Preliminary Identification of Claim Terms Requiring Construction filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Oct 29, 2021 | 49 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Preliminary Identification of Claim Terms Requiring Construction filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Oct 20, 2021 | 47 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Preliminary Invalidity Contentions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Oct 20, 2021 | 48 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Aug 5, 2021 | 46 | Answer to Amended Complaint (30) Docket Text: ANSWER to [41] Amended Complaint, and Additional Defenses, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) Modified on 8/6/2021 (nms). |
| Jun 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [45] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: MSN Laboratories Private Limited answer due 8/5/2021; MSN Pharmaceuticals Inc. answer due 8/5/2021). Signed by Judge Richard G. Andrews on 6/29/2021. (nms) |
| Jun 28, 2021 | 44 | Order (10) Docket Text: SO ORDERED Granting [43] Stipulated Proposed Amended Scheduling Order (*Reset Deadlines/Hearings; Fact Discovery completed by 9/16/2022, Joint Claim Construction Brief due by 4/22/2022, A 3 day Bench Trial is set to start 4/10/2023, at 8:30 AM in Courtroom 6A, A Markman Hearing is set for 5/25/2022, at 8:30 AM in Courtroom 6A, A Pretrial Conference is set for 3/31/2023, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 6/28/2021. (nms) |
| Jun 28, 2021 | 45 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) Modified on 6/29/2021 (nms). |
| Jun 25, 2021 | 43 | Proposed Order (10) Docket Text: PROPOSED Amended Scheduling Order, by Currax Pharmaceuticals LLC. (O'Brien, Daniel) Modified on 6/25/2021 (nms). |
| Jun 24, 2021 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Jennifer L. Hall to handle all discovery disputes including any that arise in connection with expert reports. (nms) |
| Jun 24, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Court's website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. ORDERED by Judge Jennifer L. Hall on 6/24/2021. (ceg) |
| Jun 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [39] Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 6/21/2021. (nms) |
| Jun 21, 2021 | 40 | Order (1) Docket Text: ORDER Granting [38] UNOPPOSED Motion for Leave to File First Amended Complaint. Signed by Judge Richard G. Andrews on 6/21/2021. (nms) |
| Jun 21, 2021 | 41 | Amended Complaint (19) Docket Text: FIRST AMENDED COMPLAINT for Patent Infringement against MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.- filed by Currax Pharmaceuticals LLC.(nms) |
| Jun 21, 2021 | 41 | Amended Complaint* (1) |
| Jun 18, 2021 | 38 | Main Document (6) Docket Text: UNOPPOSED Motion for Leave to File First Amended Complaint - filed by Currax Pharmaceuticals LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Proposed Order)(O'Brien, Daniel) Modified on 6/18/2021 (nms). |
| Jun 18, 2021 | 38 | Exhibit A (19) |
| Jun 18, 2021 | 38 | Exhibit B (20) |
| Jun 18, 2021 | 38 | Exhibit C (1) |
| Jun 18, 2021 | 38 | Text of Proposed Order Proposed Order (1) |
| Jun 18, 2021 | 39 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Extending Deadline to Serve Opening Claim Construction Brief, by Currax Pharmaceuticals LLC. (O'Brien, Daniel) Modified on 6/18/2021 (nms). |
| Jun 1, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for Appendix A at D.I. [35] has been replaced with a corrected version per counsel's request. Missing pages have been added to the filing. The NEF has been regenerated. (nms) |
| May 28, 2021 | 37 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of First Set of Requests for the Production of Documents and Things (Nos. 1-92) to Plaintiff Currax Pharmaceuticals LLC filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| May 27, 2021 | 36 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-73) filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| May 14, 2021 | 35 | Main Document (3) Docket Text: Claim Construction Chart, by Currax Pharmaceuticals LLC. (Attachments: # (1) Appendix A, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J)(O'Brien, Daniel) Modified on 5/17/2021 (nms). (Attachment 1 replaced on 6/1/2021) (nms). |
| May 14, 2021 | 35 | Appendix A - DISPUTED CLAIM TERMS AND PROPOSED CONSTRUCTIONS (13) |
| May 14, 2021 | 35 | Exhibit A - U.S. Patent No. 7,915,307 (15) |
| May 14, 2021 | 35 | Exhibit B - U.S. Patent No. 9,532,971 (48) |
| May 14, 2021 | 35 | Exhibit C - U.S. Patent No. 9,572,814 (17) |
| May 14, 2021 | 35 | Exhibit D - U.S. Patent No. 9,907,780 (49) |
| May 14, 2021 | 35 | Exhibit E - U.S. Patent No. 10,548,871 (42) |
| May 14, 2021 | 35 | Exhibit F - U.S. Patent No. 10,653,660 (18) |
| May 14, 2021 | 35 | Exhibit G - Excerpts of Prosecution History for U.S. Patent No. 7,915,307 (140) |
| May 14, 2021 | 35 | Exhibit H - Excerpts of Prosecution History for U.S. Patent No. 9,532,971 (32) |
| May 14, 2021 | 35 | Exhibit I - Excerpts of Prosecution History for U.S. Patent No. 9,572,814 (160) |
| May 14, 2021 | 35 | Exhibit J - Excerpts of Prosecution History for U.S. Patent No. 10,653,660 (79) |
| Apr 27, 2021 | 34 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Currax Pharmaceuticals LLC's Preliminary Identification of Claim Terms Requiring Construction filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Apr 23, 2021 | 33 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Preliminary Identification of Claim Terms Requiring Construction filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Apr 14, 2021 | 32 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Currax Pharmaceuticals LLC's Initial Infringement Contentions filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Apr 13, 2021 | 31 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Preliminary Invalidity Contentions for U.S. Patent Nos. 7,915,307, 9,532,971, 9,572,814, 9,907,780, 10,548,871, and 10,653,660 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Mar 31, 2021 | N/A | Order Setting Mediation Conferences (0) Docket Text: ORAL ORDER Setting Mediation Conferences: The Mediation Conference with Judge Mary Pat Thynge scheduled for 4/20/2021 at 10:00 AM Eastern has been rescheduled for 5/24/2021 at 10:00 AM Eastern. Submissions shall now be due on or before 5/10/2021, by no later than 3:30 PM Eastern, with both the original and a copy of the submissions delivered to the Clerk's Office by this time. All other provisions of the Court's Order dated 2/3/2021 remain in full force and effect.. Ordered by Judge Mary Pat Thynge on 3/31/2021. (Taylor, Daniel) |
| Feb 3, 2021 | 29 | Order Setting Mediation Conferences (8) Docket Text: ORDER Setting Mediation Conferences: A Mediation Conference is set for 4/20/2021 at 10:00 AM Eastern Time before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/3/21. (cak) |
| Jan 19, 2021 | 27 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Belgam, Neal) |
| Jan 19, 2021 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Rule 26(a) Initial Disclosures filed by Currax Pharmaceuticals LLC.(O'Brien, Daniel) |
| Jan 11, 2021 | 24 | Order (17) Docket Text: SO ORDERED Granting [23] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 1/11/2021. (nms) |
| Jan 11, 2021 | 25 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Rule 26(a) Initial Disclosures filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Jan 11, 2021 | 26 | Notice of Service (1) Docket Text: NOTICE OF SERVICE of Supplemental Rule 26(a)(1) Initial Disclosures filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Ormerod, Eve) |
| Jan 8, 2021 | 23 | Main Document (15) Docket Text: PROPOSED Stipulated Protective Order, by Currax Pharmaceuticals LLC. (Attachments: # (1) Exhibit A)(O'Brien, Daniel) Modified on 1/8/2021 (nms). |
| Jan 8, 2021 | 23 | Exhibit A (2) |
| Dec 9, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Dec 9, 2020 | 20 | Scheduling Order (9) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. This matter will be referred to a magistrate judge should any discovery disputes arise. Joinder of Parties due by 6/18/2021. Amended Pleadings due by 6/18/2021. Fact Discovery completed by 12/17/2021. Joint Claim Construction Brief due by 9/17/2021. A Markman Hearing is set for 10/12/2021, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 8/26/2022, at 8:30 AM in Courtroom 6A. A 3 day Bench Trial is set to start 9/12/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 12/9/2020. (nms) |
| Dec 9, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference set for 12/10/2020, is CANCELED. Ordered by Judge Richard G. Andrews on 12/9/2020. (nms) |
| Dec 9, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before 1/8/21 by a JOINT EMAIL to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. When referencing the timing for mediation, counsel rely on certain events in the scheduling order, for example, before claim construction briefing, after the close of discovery, before expert reports and the like, they are to include the date(s) on when such event(s) occur. Ordered by Chief Magistrate Judge Mary Pat Thynge on 12/9/20. (cak) |
| Dec 8, 2020 | 19 | Proposed Order (9) Docket Text: PROPOSED Scheduling Order, by Currax Pharmaceuticals LLC. (O'Brien, Daniel) Modified on 12/8/2020 (nms). |
| Dec 4, 2020 | 18 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Daniel A. O'Brien, regarding Dial-In Information for Rule 16(b) Telephonic Scheduling Conference. (O'Brien, Daniel) Modified on 12/4/2020 (nms). |
| Dec 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Stuart D. Sender and Amit Singhai for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Dec 2, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pro hac motions filed at D.I. 12 and 13 have been removed from the docket per counsel's request. The motions will be refiled. (nms) |
| Dec 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Christopher P. Borello, Esq., filed by Currax Pharmaceuticals LLC, [14] MOTION for Pro Hac Vice Appearance of Attorney Zachary L. Garrett, Esq., filed by Currax Pharmaceuticals LLC, and [16] MOTION for Pro Hac Vice Appearance of Attorney Dominick A. Conde, Esq., filed by Currax Pharmaceuticals LLC. Signed by Judge Richard G. Andrews on 12/2/2020. (nms) |
| Dec 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] MOTION for Pro Hac Vice Appearance of Attorney Stuart D. Sender and Amit Singhai, filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/2/2020. (nms) |
| Dec 2, 2020 | 14 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Zachary L. Garrett, Esquire - filed by Currax Pharmaceuticals LLC. (Attachments: # (1) Certification, # (2) Certificate of Service)(O'Brien, Daniel) Modified on 12/2/2020 (nms). |
| Dec 2, 2020 | 14 | Certification of Counsel to be Admitted Pro Hac Vice (1) |
| Dec 2, 2020 | 14 | Certificate of Service (1) |
| Dec 2, 2020 | 15 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher P. Borello, Esquire - filed by Currax Pharmaceuticals LLC. (Attachments: # (1) Certification, # (2) Certificate of Service)(O'Brien, Daniel) Modified on 12/2/2020 (nms). |
| Dec 2, 2020 | 15 | Certification of Counsel to be Admitted Pro Hac Vice (1) |
| Dec 2, 2020 | 15 | Certificate of Service (1) |
| Dec 2, 2020 | 16 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dominick A. Conde, Esquire - filed by Currax Pharmaceuticals LLC. (Attachments: # (1) Certification, # (2) Certificate of Service)(O'Brien, Daniel) Modified on 12/2/2020 (nms). |
| Dec 2, 2020 | 16 | Certification of Counsel to be Admitted Pro Hac Vice (1) |
| Dec 2, 2020 | 16 | Certificate of Service (1) |
| Dec 2, 2020 | 17 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stuart D. Sender and Amit Singhai - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) |
| Dec 1, 2020 | 10 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 12/10/2020, at 3:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 12/1/2020. (nms) |
| Dec 1, 2020 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Currax Holdings USA LLC for Currax Pharmaceuticals LLC filed by Currax Pharmaceuticals LLC. (O'Brien, Daniel) |
| Nov 25, 2020 | 8 | Answer to Complaint (23) Docket Text: ANSWER to [1] Complaint, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Belgam, Neal) |
| Nov 25, 2020 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Ltd. for MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Ormerod, Eve) |
| Nov 23, 2020 | 7 | Main Document (2) Docket Text: SUMMONS Returned Executed by Currax Pharmaceuticals LLC. MSN Laboratories Private Limited served on 11/9/2020, answer due 11/30/2020. (Attachments: # (1) Affidavit, # (2) Exhibit A, # (3) Exhibit B)(O'Brien, Daniel) Modified on 11/23/2020 (nms). |
| Nov 23, 2020 | 7 | Affidavit of Service regarding Summons, Complaint (3) |
| Nov 23, 2020 | 7 | Exhibit A - Proof of Service of Summons, Complaint via Certified Mail, Return Re (4) |
| Nov 23, 2020 | 7 | Exhibit B - Proof of Summons, Complaint via Special Process Server (3) |
| Nov 6, 2020 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Currax Pharmaceuticals LLC. MSN Pharmaceuticals Inc. served on 11/4/2020, answer due 11/25/2020. (O'Brien, Daniel) |
| Nov 3, 2020 | 5 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg) |
| Aug 19, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Aug 13, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (myr) |
| Aug 13, 2020 | 1 | Main Document (15) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3127369.) - filed by Currax Pharmaceuticals LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Civil Cover Sheet)(myr) |
| Aug 13, 2020 | 1 | Exhibit A (15) |
| Aug 13, 2020 | 1 | Exhibit B (48) |
| Aug 13, 2020 | 1 | Exhibit C (17) |
| Aug 13, 2020 | 1 | Exhibit D (49) |
| Aug 13, 2020 | 1 | Exhibit E (42) |
| Aug 13, 2020 | 1 | Exhibit F (18) |
| Aug 13, 2020 | 1 | Civil Cover Sheet (1) |
| Aug 13, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Aug 13, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 30, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 12/30/2022. (myr) |
| Aug 13, 2020 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (myr) |
